發(fā)布時(shí)間：2017-03-28
報(bào)告題目：Immune Oncology: An Industry perspective on recent history and future opportunities
報(bào)告人：Dr. Allen Ebens (NGM Bio)
時(shí)間：2017年4月7日15:30-17:00
地點(diǎn)：廣州生物醫(yī)藥與健康研究院A326
主持人：陳凌 研究員
報(bào)告人簡(jiǎn)歷: Allen earned his B.Sc. in Chemistry at the University of Washington and Ph.D. in Molecular Biology at the University of California, Los Angeles. After brief postdoctoral training at the University of California, San Francisco, Allen began a career of more than 20 years in oncology drug discovery including 11 years at Genentech where his team advanced 6 molecules to from concept-to-clinic and was responsible to lead the immune oncology research team for three years. Currently, Allen leads oncology efforts at NGM Biopharmaceuticals in San Francisco.
附件下載：
